A comprehensive study of 33 tumor types found a variety of common fusion neoantigens, including TMPRSS2-ERG, MYB-NFIB, EML4-ALK, DEK-AFF2, CBFB-MYH11, and SYT-SSX [35–38]. This evidence concerns the gene ALK and neoplasm.